[Grapefruit juice interactions with psychotropic drugs: advantages and potential risk].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Pawełczyk T;Pawełczyk T; Kłoszewska I
  • Source:
    Przeglad lekarski [Przegl Lek] 2008; Vol. 65 (2), pp. 92-5.
  • Publication Type:
    English Abstract; Journal Article; Review
  • Language:
    Polish
  • Additional Information
    • Transliterated Title:
      Interakcje leków psychotropowych z sokiem grejpfrutowym: korzyści i potencjalne ryzyko.
    • Source:
      Publisher: Wydawnicto Przeglad Lekarski Country of Publication: Poland NLM ID: 19840720R Publication Model: Print Cited Medium: Print ISSN: 0033-2240 (Print) Linking ISSN: 00332240 NLM ISO Abbreviation: Przegl Lek Subsets: MEDLINE
    • Publication Information:
      Original Publication: Kraków : Wydawnicto Przeglad Lekarski
    • Subject Terms:
      Beverages* ; Food-Drug Interactions*; Citrus paradisi/*metabolism ; Flavonoids/*pharmacology ; Psychotropic Drugs/*pharmacology; Biological Availability ; Cytochrome P-450 CYP1A2/metabolism ; Cytochrome P-450 CYP1A2 Inhibitors ; Cytochrome P-450 CYP3A/metabolism ; Cytochrome P-450 CYP3A Inhibitors ; Cytochrome P-450 Enzyme Inhibitors ; Cytochrome P-450 Enzyme System/metabolism ; Humans ; Psychotropic Drugs/pharmacokinetics
    • Abstract:
      Clinicians perceive psycho-farmacotherapy as a real challenge mainly because of numerous adverse effects and drug interacions that may lead to potential life threatening consequences. The amount information that must be taken into account while prescribing psychotropic drugs grows day by day and it is really difficult to stay well informed. Food, like grapefruit juice (GJ), is also a significant source of interactions, which is sometimes forgotten. Grapefruit contains active bioflavonoids that may change bioavailability of many medications and raise its concentrations above toxic levels. The mechanism of interaction is complex and connected with the influence of GJ active ingredients on prehepatic metabolism and enteric absorption pathways using p-glicoprotein (PGP) and organic anion transporting polipeptide (OATP). The main direction of GJ action is inhibition of cytochrome P450 1A2 and 3A4 isoforms. A wide range of medicines used in daily psychiatric practice undergoes phase I oxidation with CYP 3A4 and 1A2 i.e.: anxiolytics, antidepressants, mood stabilizers, antipsychotics and procognitive compounds. It raises the potential risk of dangerous interactions with grapefruit juice. GJ is generally contraindicated to patients taking psychotropics and it is advised to inform patients about described interaction.
    • Number of References:
      34
    • Accession Number:
      0 (Cytochrome P-450 CYP1A2 Inhibitors)
      0 (Cytochrome P-450 CYP3A Inhibitors)
      0 (Cytochrome P-450 Enzyme Inhibitors)
      0 (Flavonoids)
      0 (Psychotropic Drugs)
      9035-51-2 (Cytochrome P-450 Enzyme System)
      EC 1.14.14.1 (Cytochrome P-450 CYP1A2)
      EC 1.14.14.1 (Cytochrome P-450 CYP3A)
    • Publication Date:
      Date Created: 20080731 Date Completed: 20081003 Latest Revision: 20141120
    • Publication Date:
      20231215
    • Accession Number:
      18663908